InvestorsHub Logo
Followers 22
Posts 2631
Boards Moderated 0
Alias Born 03/17/2016

Re: None

Thursday, 12/02/2021 5:53:12 AM

Thursday, December 02, 2021 5:53:12 AM

Post# of 933
QSAM Biosciences Activates Clinical Sites and Opens Enrollment for its Phase 1 Clinical Trial of CycloSam® for the Treatment of Bone Cancer

https://finance.yahoo.com/news/qsam-biosciences-activates-clinical-sites-140000294.html

"The initiation of our first Phase 1 clinical trial of CycloSam is an important development for QSAM as it demonstrates the potential for treating bone cancers using our new approach. We look forward to driving enrollment forward and establishing a safety profile and understanding of CycloSam’s potential for efficacy,” stated Douglas R. Baum, QSAM’s CEO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QSAM News